SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001551152-23-000004
Filing Date
2023-01-06
Accepted
2023-01-06 16:15:27
Documents
14
Period of Report
2023-01-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K abbv-20230106.htm   iXBRL 8-K 67764
2 EX-99.1 abbv-20221231nonxgaapxex991.htm EX-99.1 17189
  Complete submission text file 0001551152-23-000004.txt   342967

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abbv-20230106.xsd EX-101.SCH 4505
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abbv-20230106_def.xml EX-101.DEF 21193
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abbv-20230106_lab.xml EX-101.LAB 43814
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abbv-20230106_pre.xml EX-101.PRE 21958
8 EXTRACTED XBRL INSTANCE DOCUMENT abbv-20230106_htm.xml XML 30232
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

IRS No.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35565 | Film No.: 23515247
SIC: 2834 Pharmaceutical Preparations